Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
RDHL: RedHill Biopharma Ltd. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
RDHL
The Story
RDHL
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-96.4% / yr
Operating margin
-107.3%
ROIC
-69.6%
Financially safe
Stretched
Debt / equity
0.25×
Interest coverage
-4.3×
Current ratio
0.34×
RedHill Biopharma Ltd.
RDHL
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
RedHill Biopharma Ltd.
RDHL
NASDAQ
·
USD
·
Closed
$0.65
+3.06%
$0.65
+$0.02 (3.06%)
52W Range
1th
pctl
Volume
0.06×
avg
Mkt Cap
2.04M
USD
P/E
-0.3
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
0.06×
avg
Market Cap
2.04M
USD
P/E Ratio
-0.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings